Literature DB >> 27923511

Medication-related osteonecrosis of the jaw associated with aflibercept.

P Zarringhalam1, E Brizman2, K Shakib3.   

Abstract

Entities:  

Keywords:  Aflibercept; Chemotherapy; Medication Related; Osteonecrosis

Mesh：

Substances：

Year:  2016        PMID： 27923511     DOI： 10.1016/j.bjoms.2016.11.315

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN： 0266-4356            Impact factor:   1.651


× No keyword cloud information.
  4 in total

1.  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Authors:  Ourania Nicolatou-Galitis; Maria Kouri; Erofili Papadopoulou; Emmanouil Vardas; Dimitra Galiti; Joel B Epstein; Sharon Elad; Giuseppina Campisi; Nikolaos Tsoukalas; Kivanc Bektas-Kayhan; Winston Tan; Jean-Jacques Body; Cesar Migliorati; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2018-10-23       Impact factor: 3.603

Review 2.  Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature.

Authors:  Kununya Pimolbutr; Stephen Porter; Stefano Fedele
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

Review 3.  The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes.

Authors:  Amerigo Giudice; Alessandro Antonelli; Emanuela Chiarella; Francesco Baudi; Tullio Barni; Anna Di Vito
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-25

Review 4.  Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors:  A Eguia; L Bagán-Debón; F Cardona
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.